EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical and Genetic Spectrum of ANO3-Related Dystonia with Treatment Responses in a Chinese Cohort

Jie-Hong Huang iD, Yang Li iD, Zhi-Meng Wan, Li-Xi Li, Ling-Jing Jin, Xin-Hua Wan

Genes · 17.06.2026 · 17 (6) · 703

DOI: 10.3390/genes17060703 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 17.06.2026. Verfasst von Jie-Hong Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurological Rehabilitation, Shanghai Disabled Persons' Federation Key Laboratory of Intelligent Rehabilitation Assistive…. Hauptthemen laut MEDLINE: Anoctamins, Dystonia, Dystonic Disorders. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National High Level Hospital Clinical Research Funding, National Key Research and Development Program, Clinical Technology Innovation Project of Shanghai Shenkang Hospital Development Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Variants in anoctamin 3 (ANO3) are linked to autosomal dominant dystonia, commonly known as DYT-ANO3 (OMIM: #615034). While craniocervical dystonia constitutes the most frequently observed phenotype, its clinical manifestations display significant heterogeneity. Nevertheless, the data concerning the genetic characteristics, clinical features, and therapeutic outcomes of ANO3-related dystonia within Asian populations remain scarce.

Methods

Whole-exome sequencing was conducted on 661 Chinese patients, comprising 356 individuals with dystonia and 305 individuals with non-dystonic movement disorders who served as an internal disease–control cohort. Candidate ANO3 variants were evaluated based on population frequency, predicted deleteriousness, ACMG criteria, and aggregate frequency analyses. A retrospective review was performed of clinical features and treatment responses.

Results

Fifteen rare ANO3 missense variants were identified in 16 patients with dystonia and one non-dystonic individual, including one pathogenic variant, six likely pathogenic variants, and nine previously unreported variants. The rare ANO3 variants were significantly enriched in the dystonia cohort compared with the controls. ANO3-related dystonia exhibited broad clinical heterogeneity, with frequent cervical involvement (62.5%) and tremulous features (75%), and occasionally extended beyond classical isolated dystonia. Oral medication and botulinum toxin showed variable benefit, whereas deep brain stimulation was associated with marked improvement in selected medically refractory patients.

Conclusions

This study broadens the genetic and clinical spectrum of ANO3-related movement disorders in a Chinese cohort. The findings support substantial clinical heterogeneity in DYT-ANO3 and suggest that deep brain stimulation, especially STN-DBS, may be considered in selected refractory cases, although further studies are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnoctaminsDystoniaDystonic DisordersHumansFemaleMaleAdultExome SequencingMiddle AgedAdolescentChildChinaYoung AdultMutation, MissenseRetrospective StudiesPhenotypeEast Asian People

Stichwörter der Autor:innen

ANO3dystoniawhole-exome sequencing

Substanzen

AnoctaminsANO3 protein, human

Autor:innen und Institutionen

  • Department of Neurology and Neurological Rehabilitation, Shanghai Disabled Persons' Federation Key Laboratory of Intelligent Rehabilitation Assistive Devices and Technologies, Yangzhi Rehabilitation Hospital (Shanghai S…
  • Neurotoxin Research Center of Key Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education, Department of Neurology, Tongji Hospital, School of Medicine, Tongji University, Shanghai 20…
  • Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
  • Collaborative Innovation Center for Brain Science, Tongji University, Shanghai 200092, China.

ORCID-Profile: Jie-Hong Huang, Yang Li

Förderung

  • National High Level Hospital Clinical Research Funding
  • National Key Research and Development Program
  • Clinical Technology Innovation Project of Shanghai Shenkang Hospital Development Center
  • National Clinical Key Specialty Construction Project of China
  • Shanghai Hospital Development Center Foundation-Shanghai Municipal Hospital Rehabilitation Medicine Specialty Alliance
  • Cooperated Laboratory with Lanzhou Biotechnique Development Company Limited, China National Biotech Group Company Limited and Tongji University
  • National Natural Science Foundation of China

Zitieren

APA

Huang, J. H., Li, Y., Wan, Z. M., Li, L. X., Jin, L. J., & Wan, X. H. (2026). Clinical and Genetic Spectrum of ANO3-Related Dystonia with Treatment Responses in a Chinese Cohort. Genes, 17(6), 703. https://doi.org/10.3390/genes17060703

Vancouver

Huang JH, Li Y, Wan ZM, Li LX, Jin LJ, Wan XH. Clinical and Genetic Spectrum of ANO3-Related Dystonia with Treatment Responses in a Chinese Cohort. Genes. 2026;17(6):703. doi:10.3390/genes17060703

BibTeX
@article{Huang2026,
  author = {Huang, Jie-Hong and Li, Yang and Wan, Zhi-Meng and Li, Li-Xi and Jin, Ling-Jing and Wan, Xin-Hua},
  title = {Clinical and Genetic Spectrum of ANO3-Related Dystonia with Treatment Responses in a Chinese Cohort},
  journal = {Genes},
  year = {2026},
  volume = {17},
  number = {6},
  pages = {703},
  doi = {10.3390/genes17060703}
}
Kostenlos starten →